Fig. 5 | Scientific Reports

Fig. 5

From: Characterization of growth differentiation factor 15 (GDF15) as a neurotropic adipokine permeable to the brain

Fig. 5

GDF15 in neurological disease groups. Panel A GDF15 concentrations in CSF are higher in patients with infectious diseases (and cardiovascular diseases) in the entire study cohort. The Kruskal-Wallis test was performed. Panel B GDF15 concentrations in CSF are higher in patients with infectious diseases when compared to matched controls. The Mann-Whitney U test was applied. Panel C GDF 15 concentrations in serum are not correlated to infectious diseases but only to cardiovascular diseases. Ctrl, control group; CD, vascular diseases; ID, infectious diseases; MS, multiple sclerosis; PC, pseudotumor cerebri. The Kruskal-Wallis test was performed.

Back to article page